Intended Use

SubtlePET is an image processing software intended for use by radiologists and nuclear medicine physicians for transfer, storage, and noise reduction of fluorodeoxyglucose (FDG) and amyloid PET images (including PET/CT and PET/MRI).

Technology

The software employs a convolutional neural network-based method that uses pixel neighborhood information and residual learning to predict noise and structural components separately, enhancing structural features while reducing noise. It operates as a DICOM node to receive, process, and forward image data, compatible with existing PACS systems or workstations, and runs on CentOS 7 Linux in a virtual machine or cloud environment.

Performance

Performance testing included design traceability, design verification confirming label compliance and software requirements, design validation testing simulating intended use, and noise reduction bench tests using human PET data showing significant quantitative improvements in image quality. Testing demonstrated the software's safety and effectiveness and substantial equivalence to the predicate device.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    8/28/2018

    3 months
  • 2

    FDA Approval

    11/30/2018

Other devices from Subtle Medical, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.